PerkinElmer confirms retirement of chief financial officer

PerkinElmer has announced that Andy Wilson, its senior vice-president and chief financial officer (CFO), will be retiring from the company next year.

Mr Wilson has occupied this role since 2009 and will be stepping down in August 2018, a date chosen to give the company sufficient time to identify a successor and to carry out a smooth transition.

An executive recruiting firm has already been selected to assist in an external search to fill the CFO position, with Mr Wilson also set to play an active role in ensuring the handover process is successful.

Robert Friel, PerkinElmer's president and chief executive officer, said: "The progress we have made in refining our portfolio and improving our financial returns during Andy's tenure has helped to position the company for accelerated growth and long-term success."

The firm is currently on track to meet its financial goals for the 2017 business year, having recently bolstered its operational capabilities by agreeing a deal to acquire Euroimmun and completing the successful divestiture of its non-core medical imaging business.

With over 20 years of experience within the science market, we at Zenopa have the knowledge, skills and expertise to help find the right job for you. To find out more about the current science roles we have available, you can search for the latest job roles, register your details, or contact the team today.